BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2026

Schedule of Cash, Cash Equivalents and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents and restricted cash from the balance sheets to the statements of cash flows (in thousands):


	March 31, 2026		December 31, 2025
Cash and cash equivalents	$	51,796	$	53,989
Restricted cash	231		231
Total cash, cash equivalents and restricted cash	$	52,027	$	54,220

Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share

Potentially dilutive securities not included in the calculation of diluted net loss per share of common stock as of the periods presented, because to do so would be anti-dilutive, were as follows:


	March 31,
	2026	2025
Shares issuable upon exercise of stock options	14,887,053	12,319,208
Shares issuable upon conversion election for term loan facility	988,142	988,142
Shares issuable upon exercise of warrant	730,769	730,769
Unvested RSUs	2,761,206	1,847,143
Total	19,367,170	15,885,262